足月小于胎龄儿多领域生长干预随机临床试验
该随机临床试验在印度南德里低资源社区纳入1300例足月小于胎龄儿,1:1分组接受整合干预包(健康、营养、早期刺激与心理社会支持)或常规政府项目照护,随访至12月龄。结果显示干预组体重、体重年龄Z评分及认知、语言、运动评分均优于常规照护组,且低体重、生长迟缓、消瘦和贫血患病率更低。
要点
- 足月小于胎龄儿接受整合干预包可改善12月龄体重和体重年龄Z评分。
- 干预组认知、语言和运动复合评分均高于常规照护组。
- 干预组低体重、生长迟缓、消瘦和贫血患病率均低于常规照护组。
核心结论
- 在足月小于胎龄儿中,整合干预包改善了12月龄体重和体重年龄Z评分。
研究设计与样本
- 研究为个体随机临床试验,在印度南德里低资源社区开展,纳入出生14天内的足月小于胎龄儿。
- 共1300例婴儿按1:1随机分组,干预组647例接受健康、营养、早期儿童刺激与心理社会支持的整合干预包,常规照护组653例接受政府项目常规照护。
- 随访至12月龄,1261例(97%)完成随访,结局评估者对分组设盲。
主要发现
- 12月龄时干预组平均体重8.0 kg(SD 0.9 kg),常规照护组7.8 kg(SD 0.9 kg),平均差0.22 kg(95%CI 0.11-0.32 kg)。
- 干预组平均体重年龄Z评分-1.3(SD 0.9),常规照护组-1.6(SD 1.0),平均差0.24(95%CI 0.14-0.35)。
- 干预组低体重23.9% vs 32.6%(风险差-8.75个百分点,95%CI -13.70至-3.80),生长迟缓20.1% vs 27.2%(风险差-7.17个百分点,95%CI -11.85至-2.49),消瘦13.9% vs 19.4%(风险差-5.52个百分点,95%CI -9.63至-1.41)。
- 干预组贫血34.0% vs 72.5%(风险差-38.49个百分点,95%CI -44.36至-32.61)。
- 干预组认知评分平均差1.73(95%CI 0.32-3.14),语言评分平均差2.74(95%CI 1.51-3.98),运动复合评分平均差2.32(95%CI 1.25-3.38);常规照护组死亡9例,干预组死亡5例。
临床怎么用
- 对足月小于胎龄儿可考虑在常规照护基础上叠加健康、营养、早期刺激与心理社会支持的整合干预,以促进生长和神经发育。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Small-for-gestational-age (SGA) infants face elevated risk of undernutrition and developmental delays. Multidomain interventions may be needed to promote growth and neurodevelopment. OBJECTIVE: To evaluate the effect of an integrated intervention package on growth and neurodevelopment in term SGA infants. DESIGN, SETTING, AND PARTICIPANTS: Individually randomized clinical trial conducted in low-resource neighborhoods of South Delhi, India. Term SGA infants were enrolled within 14 days of birth; 1300 infants were randomized and followed up to 12 months of age. Recruitment occurred from January 14, 2023, until July 31, 2024, with follow-up completed on August 6, 2025. Outcome assessors were blinded to participant allocation. INTERVENTIONS: Infants were randomized in a 1:1 ratio to receive either an integrated intervention package including health, nutrition, early child stimulation, and psychosocial support (n = 647) or usual care through government programs (n = 653). MAIN OUTCOMES AND MEASURES: The primary outcomes were weight and weight-for-age z score at 12 months. Secondary outcomes included linear growth, neurodevelopment (assessed using the Bayley Scales of Infant and Toddler Development, Third Edition), anemia, and mortality. RESULTS: At 12 months, 1261 infants (97%) (mean age, 6 days; 48.1% male) had completed follow-up. The mean weight was 8.0 kg (SD, 0.9 kg) in the intervention group vs 7.8 kg (SD, 0.9 kg) in the usual care group (mean difference, 0.22 kg [95% CI, 0.11-0.32 kg]). The mean weight-for-age z score was -1.3 (SD, 0.9) vs -1.6 (SD, 1.0), respectively (mean difference, 0.24 [95% CI, 0.14-0.35]). The intervention group had a lower prevalence of underweight (23.9% vs 32.6%; risk difference, -8.75 [95% CI, -13.70 to -3.80] percentage points), stunting (20.1% vs 27.2%; risk difference, -7.17 [95% CI, -11.85 to -2.49] percentage points), wasting (13.9% vs 19.4%; risk difference, -5.52 [95% CI, -9.63 to -1.41] percentage points), and anemia (34.0% vs 72.5%; risk difference, -38.49 [95% CI, -44.36 to -32.61] percentage points) and higher cognitive scores (mean difference, 1.73 [95% CI, 0.32-3.14]), language scores (mean difference, 2.74 [95% CI, 1.51-3.98]), and motor composite scores (mean difference, 2.32 [95% CI, 1.25-3.38]). Nine children in the usual care group and 5 in the intervention group died. CONCLUSIONS AND RELEVANCE: Among term SGA infants, an integrated intervention improved weight and weight-for-age z scores at 12 months. TRIAL REGISTRATION: Clinical Trials Registry-India Identifier: CTRI/2021/11/037881.
引用
- Chowdhury R, Manapurath R, Upadhyay RP, et al. Multidomain Intervention for Growth in Term Small-for-Gestational-Age Infants: A Randomized Clinical Trial. JAMA. 2026. PMID: 42507387. doi:10.1001/jama.2026.12117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。